// App-Quantinova.ai

218 : Defining the Optimal 14-3-3? Threshold to Predict Worse Radiographic Outcomes in Patients with Recent-Onset Inflammatory Arthritis

Researchers

Presenter

  • Anthony Marotta

Principal Investigators

  • Artur de Brum Fernandes

  • Patrick Liang

  • Ariel Masetto

  • Yuan Gui

  • Jane Savill

  • Sara Michienzi

  • Henri Menard

  • Walter Maksymowych

  • Gilles Boire

Medical Centers

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • University of Alberta, Edmonton, AB, Canada

  • Centre hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada

Locations

  • Canada

Companies

  • Augurex Life Science

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Theta

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved